ELUT Q4 2024 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena

ELUTElutia Inc.

$48M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-6.9% YoY

Gross Profit

$2M42.5% margin

Operating Income

-$8M-154.2% margin

Net Income

-$9M-165.7% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

-7.7%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$36M

Total Liabilities

$82M

Stockholders' Equity

-$46M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$6M	-6.9%
Gross Profit	$2M	$2M	+9.3%
Operating Income	-$8M	-$9M	+0.9%
Net Income	-$9M	-$9M	+2.7%

Revenue Segments

Women's Health

$6M82%

Cardiovascular

$1M18%